San Antonio, TX, United States of America

Michael J McGinity


 

Average Co-Inventor Count = 4.0

ph-index = 2

Forward Citations = 12(Granted Patents)


Company Filing History:


Years Active: 2018-2022

Loading Chart...
Loading Chart...
3 patents (USPTO):Explore Patents

Title: Michael J McGinity: Innovator in Therapeutic Delivery Systems

Introduction

Michael J McGinity is a prominent inventor based in San Antonio, TX (US). He has made significant contributions to the field of pharmaceutical implant compositions, particularly in the unidirectional delivery of therapeutic compounds to the brain. With a total of 3 patents, his work focuses on innovative solutions for treating brain tumors.

Latest Patents

One of McGinity's latest patents is titled "Implant compositions for the unidirectional delivery of therapeutic compounds to the brain." This invention provides bilayered and trilayered pharmaceutical implant compositions designed for the unidirectional delivery of anti-cancer compounds to the brain over an extended period. This delivery method is particularly beneficial following the removal of glioblastoma multiforme or other malignant tumors in the brain.

Career Highlights

Michael J McGinity is affiliated with the University of Texas System, where he continues to advance research in therapeutic delivery systems. His innovative approaches have garnered attention in the medical community, particularly for their potential to improve treatment outcomes for patients with brain tumors.

Collaborations

Throughout his career, McGinity has collaborated with notable colleagues, including Feng Zhang and John R Floyd. These partnerships have contributed to the development of groundbreaking technologies in the field of pharmaceuticals.

Conclusion

Michael J McGinity's work exemplifies the impact of innovation in medical technology. His contributions to the unidirectional delivery of therapeutic compounds are paving the way for more effective treatments for brain cancer.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…